Roivant Sciences Company
Computational platform for drug discovery coupled with a technology-enabled "Vant" model to rapidly develop assets.
Investors
Connections from
Headquarters:
UK / USA
Founded Date:
2014
Industry:
End-to-End Drug Development
Employee Number:
501-1000
Total Funding:
> $6 B